In assessing virus-specific CD4+ and CD8+ T cells by AIM assay, we found that frequencies of AIM+CD4+ or AIM+CD8+ T cells were similar at two weeks post-infection, but that activated, virus-specific CD4+ T cells appeared to decline slightly over the six months of follow-up compared to AIM+CD8+ T cells. The gene discussed is CD8A; the disease is infection.